Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 18, 2012 BIODELIVERY SCIENCES INTL (NASDAQ:BDSI), Up By 11.68% ($0.34) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, April
April 18, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, released a report on Tuesday, April 17th 2012 at 07:16:00 PDT stating that BIODELIVERY SCIENCES INTL (NASDAQ:BDSI) was expected to be Up After it crossed above its SqueezeTrigger Price of 2.91 on Tuesday, April 17th 2012. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=bdsi&id=264931
From August 2009 to March 2012, an aggregate amount of 34651842 shares of BDSI have been shorted for a total dollar value of $69303684. The BDSI SqueezeTrigger price of $2.91 is the volume weighted average price that all shorts are short in shares of BDSI. There is still approximately $1,541,322 of potential short covering in shares of BDSI.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com .
BIODELIVERY SCIENCES INTL (NASDAQ:BDSI) - BioDelivery Sciences International, Inc. operates as a specialty pharmaceutical company in the United States. The company focuses on developing products in the areas of pain management and oncology supportive care. Its patented drug delivery technologies include the BioErodible MucoAdhesive (BEMA) technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek); and the Bioral cochleate drug delivery technology for the potential oral delivery of range of products otherwise administered intravenously. The company principally offers two pain products that utilize its BEMA buccal soluble film technology: ONSOLIS and BEMA Buprenorphine. ONSOLIS was approved by FDA for the management of breakthrough pain in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. It licensed the commercial rights of ONSOLIS to Meda AB. BEMA Buprenorphine is in Phase 2 clinical development for the treatment of chronic pain, and in a higher dose formulation for the treatment of opioid dependence. The company is also developing other product candidates utilizing the BEMA technology for various conditions, such as nausea/vomiting (BEMA Granisetron) and migraine (BEMA Triptan). BioDelivery Sciences International, Inc. was founded in 1997 and is based in Raleigh, North Carolina.
The SqueezeTrigger database of approximately 1 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.
INVESTMENTS & TRADING
SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.
GATS -- tracks and quantifies known trading strategies.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net
- WOPRAI
- support@woprai.com